CHICAGO — Acute lymphoblastic leukemia (ALL) remains challenging to treat in older adult patients due to biological factors ...

Global Location Strategies (GLS), the world's leading location strategy and site selection advisory firm, today announced that Phil Schneider, a distinguished veteran in corporate site selection and ...

Public exchange offer for all shares of CureVac where each share of CureVac will be exchanged for approx. $5.46 in BioNTech American Depositary Shares (“ADSs”), representing a premium of 55% to ...